Wenfeng Hu Selected Research

poncirin

2/2022

Poncirin ameliorates cardiac ischemia-reperfusion injury by activating PI3K/AKT/PGC-1α signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenfeng Hu Research Topics

Disease

8	Neoplasms (Cancer) 03/2022 - 10/2016
4	Neuroinflammatory Diseases 01/2021 - 04/2016
3	Hypoxia (Hypoxemia) 02/2022 - 01/2020
2	Carcinogenesis 03/2022 - 10/2016
2	Ventricular Tachycardia 01/2021 - 01/2021
1	Genomic Instability 03/2022
1	Reperfusion Injury 02/2022
1	Infarction (Infarctions) 02/2022
1	Ischemia 02/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Silicosis 01/2022
1	Myocardial Infarction 01/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Nasopharyngeal Carcinoma 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Ventricular Fibrillation 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Heart Failure 01/2021
1	Cardiotoxicity 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Wilms Tumor (Wilm's Tumor) 07/2018
1	Atherosclerosis 09/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Brain Ischemia (Cerebral Ischemia) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2016
1	Adenocarcinoma 10/2016
1	Ovarian Neoplasms (Ovarian Cancer) 04/2012

Drug/Important Bio-Agent (IBA)

2	N-Type Calcium Channels (N-Type Calcium Channel)IBA 01/2022 - 01/2021
2	Vanillic AcidIBA 01/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2012
2	Small Interfering RNA (siRNA)IBA 01/2021 - 04/2012
2	CytokinesIBA 04/2019 - 09/2017
1	RNA Helicases (RNA Helicase)IBA 03/2022
1	poncirinIBA 02/2022
1	AntioxidantsIBA 02/2022
1	FlavonoidsIBA 02/2022
1	GlycosidesIBA 02/2022
1	Ribosomal DNA (rDNA)IBA 01/2022
1	UteroglobinIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022
1	RNA Polymerase I (Polymerase I, RNA)IBA 01/2022
1	TubulinIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022
1	Liposomes (Liposome)IBA 01/2021
1	Clodronic Acid (Clodronate)IBA 01/2021
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 01/2020
1	Plant ExtractsIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Pharmaceutical PreparationsIBA 04/2019
1	MicroRNAs (MicroRNA)IBA 04/2019
1	Sirolimus (Rapamycin)FDA Link 04/2019
1	Chloroquine (Aralen)FDA LinkGeneric 04/2019
1	Glutamine (L-Glutamine)FDA Link 01/2019
1	AntigensIBA 07/2018
1	CarbohydratesIBA 01/2018
1	KetonesIBA 01/2018
1	pirinixic acidIBA 01/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017
1	StilbenesIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2017
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 10/2016
1	Crystallins (Crystallin)IBA 10/2016
1	Small Heat-Shock ProteinsIBA 10/2016
1	pregna-4,17-diene-3,16-dione (guggulsterone)IBA 04/2016
1	Cisplatin (Platino)FDA LinkGeneric 04/2012

Therapy/Procedure

4	Radiotherapy 01/2022 - 01/2019
1	Ligation 01/2021
1	Immunotherapy 07/2018
1	Ketogenic Diet 01/2018
1	Therapeutics 04/2016